莫努匹韦应该怎么服用？莫努匹韦需要注意什么？

The RNA polymerase inhibitor monupivir is suitable for adult patients with mild to moderate coronavirus disease 2019 (COVID-19). It is a small molecule drug targeting coronavirus. It is the first oral antiviral drug in the world approved for the treatment of mild to moderate COVID-19 infection in adults.

So, how should you take Monupivir?

Monupivir is a 200 mg capsule that should be swallowed whole with plenty of liquid (such as a glass of water). Monupivir can be taken with or without food, and the recommended dose for adults is 800 mg (four 200 mg capsules) taken orally every 12 hours for 5 days. Monupivir should be taken as soon as possible after diagnosis of COVID-19 or within 5 days of the onset of symptoms, but the safety and effectiveness of dosing beyond 5 days have not been established. Patients must follow the doctor's instructions and do not change the dosage and usage at will to avoid intolerance reactions and affect the condition.

So, what should we pay attention to when treating Monupivir? Monupivir has the advantages of low cost, convenient administration, and easy expansion of production. It can inhibit the replication of a variety of RNA viruses, including the new coronavirus. Based on the limited available data on Monupivir, no drug interactions have been established; the drug contains less than 1 mmol sodium (23 mg) per dose of 4 capsules, i.e., is essentially "sodium-free"; use of Monupivir is not recommended during pregnancy; breastfeeding is not recommended during treatment and within 4 days after the last dose of Monupivir; There have been no cases of overdose of Monupivir in humans. The adverse reactions of this product are mostly mild or moderate, with the main manifestations being nausea, diarrhea, dizziness, and headache.

Note: The above information comes from the Internet and is compiled and edited by Medical Companion Travel (please correct me if there are any errors or omissions). It is only to provide information on the latest drugs on the market in the world and help Chinese patients understand the latest international new drug trends. It is only for internal discussion among medical staff and does not serve as any basis for medication. For specific medication guidelines, please consult the attending physician.

Recommended related articles: